Pharmaceuticals & Life Sciences

Corporate AI Training for Pharmaceuticals & Life Sciences

Corporate AI Training for pharmaceuticals & life sciences, built around the constraint that defines the sector: GxP validation means every system change needs documented evidence before it reaches production.

Regulations in scope
5
Systems we integrate
5
Typical first release
6 weeks

What changes when it is pharmaceuticals & life sciences

Generic AI training does not survive contact with Monday. We build the exercises on your systems, with your data, so what people learn is immediately usable.

In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how corporate ai training has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.

The workload we are most often asked to take on first is literature monitoring, usually integrated against SAP. We start from the constraint, not the capability, what the system must never do, who signs off, and what happens when it is wrong.

Deployed across regulated and unregulated sectors, with audit trails where the regulator expects them. You own the code, the models where they are open-weight, and the documentation to run it without us.

The sector constraints we design around

Defining constraint
GxP validation means every system change needs documented evidence before it reaches production
Regulations in scope
CDSCO · US FDA 21 CFR Part 11 · EU GMP Annex 11 · GxP validation · ICH guidelines
Systems of record
LIMS · QMS · eTMF · SAP · pharmacovigilance databases
Where we usually start
batch record review

Corporate AI Training workloads in pharmaceuticals & life sciences

  • batch record review
  • adverse event intake and coding
  • regulatory dossier assembly
  • deviation and CAPA drafting
  • literature monitoring

What is included

  • Role-specific tracks for leaders, engineers and operations
  • Hands-on exercises on your own systems and data
  • Safe-use policy and practical guardrails
  • Prompt and workflow patterns people keep using afterwards
  • Assessment and certification
  • Follow-up clinic weeks after the session

Questions from this sector

Can an AI system be GxP validated?

Yes, with a documented validation approach, IQ/OQ/PQ, defined intended use, change control and evidence of consistent performance. We build the validation pack alongside the system, not afterwards.

How do you handle 21 CFR Part 11?

Audit trails, electronic signatures, access control and record integrity designed in from the start, because retrofitting them is effectively a rebuild.

Can you train non-technical teams?

Yes, separate tracks for leadership, operations and engineering, pitched at genuinely different depths rather than the same deck at different speeds.

Is it remote or on-site?

Either. On-site tends to work better for hands-on engineering sessions; leadership briefings run well remotely.

What do people take away?

Working prompts and workflows on their own systems, a safe-use policy, and a follow-up clinic to unstick what they hit in practice.

Corporate AI Training for pharmaceuticals & life sciences, worth a conversation?

Tell us the workload and the regulation it sits under. We will tell you what is realistic.

Or email bd@dtrasglobal.com · call +91 74118 77878